[1]
|
Klemen, N.D., Feingold, P.L., Hashimoto, B., Wang, M., Kleyman, S., Brackett, A., Gross, C.P., Pei, K.Y. (2020) Mor-tality Risk Associated with Venous Thromboembolism: A Systematic Review and Bayesian Meta-Analysis. The Lancet Haematology, 7, e583-e593. https://doi.org/10.1016/S2352-3026(20)30211-8
|
[2]
|
Stein, P. D., Kayali, F., Olson, R.E. and Milford, C.E. (2004) Pulmonary Thromboembolism in Asians/Pacific Islanders in the United States: Analysis of Data from the National Hospital Discharge Survey and the United States Bureau of the Census. The American Journal of Medicine, 116, 435-442. https://doi.org/10.1016/j.amjmed.2003.11.020
|
[3]
|
Barco, S., Mahmoudpour, S.H., Valerio, L., Klok, F.A., Münzel, T., Middeldorp, S., Ageno, W., Cohen, A.T., Hunt, B. J., Konstantinides, S.V., et al. (2020) Trends in Mortality Related to Pulmonary Embolism in the European Region, 2000-2015: Analysis of Vital Reg-istration Data from the WHO Mortality Database. The Lancet Respiratory Medicine, 8, 277-287. https://doi.org/10.1016/S2213-2600(19)30354-6
|
[4]
|
Barco, S., Woersching, A.L., Spyropoulos, A.C., Piovella, F. and Mahan, C.E. (2016) European Union-28: An Annualised Cost-of-Illness Model for Venous Thromboembolism. Thromb Haemost, 115, 800-808.
https://doi.org/10.1160/TH15-08-0670
|
[5]
|
Konstantinides, S.V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.J., Harjola, V.P., Huisman, M.V., Humbert, M., Jennings, C.S., Jiménez, D., et al. (2020) 2019 ESC Guidelines for the Diagnosis and Management of Acute Pulmonary Embolism Developed in Collaboration with the European Respira-tory Society (ERS). European Heart Journal, 41, 543-603. https://doi.org/10.1093/eurheartj/ehz405
|
[6]
|
Saha, P., Humphries, J., Modarai, B., Mattock, K., Waltham, M., Evans, C.E., Ahmad, A., Patel, A.S., Premaratne, S., Lyons, O.T., et al. (2011) Leukocytes and the Natural History of Deep Vein Thrombosis: Current Concepts and Future Direc-tions. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 506-512.
https://doi.org/10.1161/ATVBAHA.110.213405
|
[7]
|
Piazza, G. (2015) Beyond Virchow’s Triad: Does Cardio-vascular Inflammation Explain the Recurrent Nature of Venous Thromboembolism? Vascular Medicine, 20, 102-104. https://doi.org/10.1177/1358863X14568706
|
[8]
|
Mackman, N. (2012) New Insights into the Mechanisms of Ve-nous Thrombosis. Journal of Clinical Investigation, 122, 2331-2336. https://doi.org/10.1172/JCI60229
|
[9]
|
Koupenova, M., Kehrel, B.E., Corkrey, H.A., Freedman, J.E. (2017) Thrombosis and Platelets: An Update. European Heart Journal, 38, 785-791. https://doi.org/10.1093/eurheartj/ehw550
|
[10]
|
Savchenko, A.S., Martinod, K., Seidman, M.A., Wong, S.L., Borissoff, J.I., Piazza, G., Libby, P., Goldhaber, S.Z., Mitchell, R.N., Wagner, D.D., et al. (2014) Neutrophil Extracellu-lar Traps form Predominantly during the Organizing Stage of Human Venous Thromboembolism Development. Journal of Thrombosis and Haemostasis, 12, 860-870.
https://doi.org/10.1111/jth.12571
|
[11]
|
Xu, X., Wu, Y., Xu, S., Yin, Y., Ageno, W., de Stefano, V., Zhao, Q. and Qi, X. (2022) Clinical Significance of Neutrophil Extracellular Traps Biomarkers in Thrombosis. Thrombosis Journal, 20, Article No. 63.
https://doi.org/10.1186/s12959-022-00421-y
|
[12]
|
Beutler, B.A. (2009) TLRs and Innate Immunity. Blood, 113, 1399-1407.
https://doi.org/10.1182/blood-2008-07-019307
|
[13]
|
Fitzgerald, K.A. and Kagan, J.C. (2020) Toll-Like Receptors and the Control of Immunity. Cell, 180, 1044-1066.
https://doi.org/10.1016/j.cell.2020.02.041
|
[14]
|
Heestermans, M., Poenou, G., Duchez, A.C., Hamzeh-Cognasse, H., Bertoletti, L. and Cognasse, F. (2022) Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases. International Journal of Molecular Sciences, 23, Article 13176. https://doi.org/10.3390/ijms232113176
|
[15]
|
Heit, J. A., Spencer, F.A. and White, R.H. (2016) The Epidemiology of Venous Thromboembolism. Journal of Thrombosis and Thrombolysis, 41, 3-14. https://doi.org/10.1007/s11239-015-1311-6
|
[16]
|
Shatzel, J. J., Connelly, K.J. and De-Loughery, T.G. (2017) Thrombotic Issues in Transgender Medicine: Areview. American Journal of Hematology, 92, 204-208. https://doi.org/10.1002/ajh.24593
|
[17]
|
Elisia, I. et al. (2020) The Effect of Smoking on Chronic Inflam-mation, Immune Function and Blood Cell Composition. Scientific Reports, 10, Article No. 19480. https://doi.org/10.1038/s41598-020-76556-7
|
[18]
|
Mahmoodi, B.K., et al. (2017) Association of Traditional Car-diovascular Risk Factors with Venous Thromboembolism: an Individual Participant Data Meta-Analysis of Prospective Studies. Circulation, 135, 7-16.
https://doi.org/10.1161/CIRCULATIONAHA.116.024507
|
[19]
|
Bai, J., Ding, X., Du, X., Zhao, X., Wang, Z. and Ma, Z. (2015) Diabetes Is Associated with Increased Risk of Venous Thromboembolism: Asystematic Review and Me-ta-Analysis. Thrombosis Research, 135, 90-95.
https://doi.org/10.1016/j.thromres.2014.11.003
|
[20]
|
Charlier, S.H.R., Meier, C., Jick, S.S., Meier, C.R. and Becker, C. (2022) Association between Glycemic Control and Risk of Venous Thromboem Bolism in Diabetic Patients: A Nested Case-Control Study. Cardiovascular Diabetology, 21, Article No. 2. https://doi.org/10.1186/s12933-021-01432-1
|
[21]
|
Gariani, K., Mavrakanas, T., Combescure, C., Perrier, A. and Marti, C. (2016) Is Diabetes Mellitus a Risk Factor for Venous Thromboembolism? A Systematic Review and Me-ta-Analysis of Case-Control and Cohort Studies. European Journal of Internal Medicine, 28, 52-58. https://doi.org/10.1016/j.ejim.2015.10.001
|
[22]
|
Phasha, M.N., Soma, P., Bester, J., Pretorius, E. and Phulukdaree, A. (2022) Factor XIII-A Val34Leu and Tyr204Phe Variants Influence Clot Kinetics in a Cohort of South African Type 2 Diabetes Mellitus Patients. Gene, 834, Article ID: 146637. https://doi.org/10.1016/j.gene.2022.146637
|
[23]
|
Zhang, Q., Jin, Y., Li, X., Peng, X., Peng, N., Song, J. and Xu, M. (2020) Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Promoter Polymorphisms and Risk of Venous Thromboembolism—A Meta-Analysis and Systematic Review. Vasa, 49, 141-146. https://doi.org/10.1024/0301-1526/a000839
|
[24]
|
Abou-Ismail, M.Y., Citla Sridhar, D. and Nayak, L. (2020) Estrogen and Thrombosis: A Bench to Bedside Review. Thrombosis Research, 192, 40-51. https://doi.org/10.1016/j.thromres.2020.05.008
|
[25]
|
Kotamarti, V.S., Greige, N., Heiman, A.J., Patel, A. and Ricci, J.A. (2021) Risk for Venous Thromboembolism in Transgender Patients Undergoing Cross-Sex Hormone Treatment: A Systematic Review. The Journal of Sexual Medicine, 18, 1280-1291. https://doi.org/10.1016/j.jsxm.2021.04.006
|
[26]
|
Rovinski, D., Ramos, R.B., Fighera, T.M., Casanova, G.K. and Spritzer, P.M. (2018) Risk of Venous Thromboembolism Events in Post Menopausal Women Using Oral Versus Non-Oral Hormone Therapy: A Systematic Review and Meta-Analysis. Thrombosis Research, 168, 83-95. https://doi.org/10.1016/j.thromres.2018.06.014
|
[27]
|
Eischer, L., Eichinger, S. and Kyrle, P.A. (2014) The Risk of Recurrence in Women with Venous Thromboembolism While Using Estrogens: A Prospective Cohort Study. Journal of Thrombosis and Haemostasis, 12, 635-640.
https://doi.org/10.1111/jth.12528
|
[28]
|
Agnelli, G., Becattini, C., Bauersachs, R., Brenner, B., Campanini, M., Co-hen, A., Connors, J.M., Fontanella, A., Gussoni, G., Huisman, M.V., et al. (2018) Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study. Thromb Haemost, 118, 1668-1678.
https://doi.org/10.1055/s-0038-1668523
|
[29]
|
Horsted, F., West, J. and Grainge, M.J. (2012) Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta Analysis. PLOS Medicine, 9, e1001275. https://doi.org/10.1371/journal.pmed.1001275
|
[30]
|
Martens, K.L., et al. (2021) HIGH-2-LOW Risk Model to Pre-dict Venous Thromboembolism in Allogeneic Transplant Patients after Platelet Engraftment. Blood Advances, 5, 167-175. https://doi.org/10.1182/bloodadvances.2020003353
|
[31]
|
Hisada, Y. and Mackman, N. (2017) Cancer-Associated Pathways and Biomarkers of Venous Thrombosis. Blood, 130, 1499-1506. https://doi.org/10.1182/blood-2017-03-743211
|
[32]
|
Garcia, D. and Erkan, D. (2018) Diagnosis and Management of the Antiphospholipid Syndrome. The New England Journal of Medicine, 379, 1289-1290. https://doi.org/10.1056/NEJMc1808253
|
[33]
|
Bucci, T., Menichelli, D., Pignatelli, P., Triggiani, M., Violi, F. and Pastori, D. (2019) Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review. Journal of Alzheimer’s Disease, 69, 561-576.
https://doi.org/10.3233/JAD-181294
|
[34]
|
Bucci, T., Ames, P.R.J., Triggiani, M., Parente, R., Ciampa, A., Pig-natelli, P. and Pastori, D. (2022) The Multicenter ATHERO-APS Study Group. Cardiac and Vascular Features of Arteri-al and Venous Primary Antiphospholipid Syndrome. The Multicenter ATHERO-APS Study. Thrombosis Research, 209, 69-74.
https://doi.org/10.1016/j.thromres.2021.12.001
|
[35]
|
Levi, M., Thachil, J., Iba, T. and Levy, J.H. (2020) Coagula-tion Abnormalities and Thrombosis in Patients with COVID-19. The Lancet Haematology, 7, e438-e440. https://doi.org/10.1016/S2352-3026(20)30145-9
|
[36]
|
Burn, E., Duarte-Salles, T., Fernandez-Bertolin, S., Reyes, C., Kostka, K., Delmestri, A., Rijnbeek, P., Verhamme, K. and Prieto Alhambra, D. (2022) Venous or Arterial Thrombosis and Deaths among COVID-19 Cases: A European Network Cohort Study. The Lancet Infectious Diseases, 22, 1142-1152.
https://doi.org/10.1016/S1473-3099(22)00223-7
|
[37]
|
Li, P., Zhao, W., Kaatz, S., Latack, K., Schultz, L. and Pois-son, L. (2021) Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19. JAMA Network Open, 4, e2135397.
https://doi.org/10.1001/jamanetworkopen.2021.35397
|
[38]
|
Engelen, M.M., Vandenbriele, C., Balthazar, T., Claeys, E., Gunst, J., Guler, I., Jacquemin, M., Janssens, S., Lorent, N., Liesenborghs, L., et al. (2021) Venous Thromboembo-lism in Patients Discharged after COVID-19 Hospitalization. Semin Thromb Hemost, 47, 362-371. https://doi.org/10.1055/s-0041-1727284
|
[39]
|
Gianni, P., Goldin, M., Ngu, S., Zafeiropoulos, S., Geropoulos, G. and Giannis, D. (2022) Complement-Mediated Microvascular Injury and Thrombosis in the Pathogenesis of Severe COVID-19: A Review. World Journal of Experimental Medicine, 12, 53-67. https://doi.org/10.5493/wjem.v12.i4.53
|
[40]
|
Tudoran, C., Velimirovici, D.E., Berceanu-Vaduva, D.M., Rada, M., Voita-Mekeres, F. and Tudoran, M. (2022) Increased Susceptibility for Thromboembolic Events versus High Bleeding Risk Associated with COVID-19. Microorganisms, 10, Article 1738. https://doi.org/10.3390/microorganisms10091738
|
[41]
|
The Lancet Haematology. (2020) COVID-19 Coagulopathy: An Evolving Story. The Lancet Haematology, 7, e425.
https://doi.org/10.1016/S2352-3026(20)30151-4
|
[42]
|
Violi, F., Pastori, D., Cangemi, R., Pignatelli, P. and Loffredo, L. (2020) Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge. Thromb Haemost, 120, 949-956.
https://doi.org/10.1055/s-0040-1710317
|
[43]
|
van Stralen, K.J., Rosendaal, F.R. and Doggen, C.J. (2008) Minor Injuries as a Risk Factor for Venous Thrombosis. Archives of Internal Medicine, 168, 21-26. https://doi.org/10.1001/archinternmed.2007.5
|
[44]
|
Goualou, M., Noumegni, S., de Moreuil, C., Le Guillou, M., de Coninck, G., Hoffmann, C., Robin, S., Morcel, K., le Moigne, E., Tremouilhac, C., et al. (2022) Venous Thromboembo-lism Associated with Assisted Reproductive Technology: A Systematic Review and Meta-Analysis. Thromb Haemost, 123, 283-294.
https://doi.org/10.1055/s-0042-1760255
|
[45]
|
Scheres, L.J.J., Lijfering, W.M., Groenewegen, N.F.M., Koole, S., de Groot, C.J.M., Middeldorp, S. and Cannegieter, S.C. (2020) Hypertensive Complications of Pregnancy and Risk of Ve-nous Thromboembolism. Hypertension, 75, 781-787. https://doi.org/10.1161/HYPERTENSIONAHA.119.14280
|
[46]
|
James, A.H., Rhee, E., Thames, B. and Philipp, C.S. (2014) Characterization of Antithrombin Levels in Pregnancy. Thrombosis Research, 134, 648-651. https://doi.org/10.1016/j.thromres.2014.07.025
|